(Q40457647)

20 September 2017

title

A single M protein mutation affects the acid inactivation threshold and growth kinetics of a chimeric flavivirus. (English)

1 reference

20 September 2017

5

Thomas P Monath

1 reference

20 September 2017

7

Farshad Guirakhoo

1 reference

20 September 2017

Caroline C Maier

1

1 reference

20 September 2017

Simon Delagrave

2

1 reference

20 September 2017

Zhen-xi Zhang

3

1 reference

20 September 2017

Nathan Brown

4

1 reference

20 September 2017

Konstantin V Pugachev

6

1 reference

20 September 2017

language of work or name

English

0 references

publication date

15 February 2007

1 reference

20 September 2017

1 reference

20 September 2017

volume

362

1 reference

20 September 2017

issue

2

1 reference

20 September 2017

page(s)

468-474

1 reference

Molecular basis for attenuation of neurovirulence of a yellow fever Virus/Japanese encephalitis virus chimera vaccine (ChimeriVax-JE).

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.01.008

Epitopes on the dengue 1 virus envelope protein recognized by neutralizing IgM monoclonal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.01.008

Analysis of the endocytic pathway mediating the infectious entry of mosquito-borne flavivirus West Nile into Aedes albopictus mosquito (C6/36) cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.01.008

Molecular organization of a recombinant subviral particle from tick-borne encephalitis virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.01.008

Epitope determinants of a chimpanzee Fab antibody that efficiently cross-neutralizes dengue type 1 and type 2 viruses map to inside and in close proximity to fusion loop of the dengue type 2 virus envelope glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.01.008

Fusion activity of flaviviruses: comparison of mature and immature (prM-containing) tick-borne encephalitis virions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.01.008

The Murray Valley encephalitis virus prM protein confers acid resistance to virus particles and alters the expression of epitopes within the R2 domain of E glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.01.008

Selection and partial characterization of dengue 2 virus mutants that induce fusion at elevated pH.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.01.008

Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.01.008

Loss of dimerisation of the nonstructural protein NS1 of Kunjin virus delays viral replication and reduces virulence in mice, but still allows secretion of NS1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.01.008

Characterization of monoclonal antibody-escape mutants of tick-borne encephalitis virus with reduced neuroinvasiveness in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.01.008

Attenuation of Murray Valley encephalitis virus by site-directed mutagenesis of the hinge and putative receptor-binding regions of the envelope protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.01.008

Class II virus membrane fusion proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.01.008

Changes in the dengue virus major envelope protein on passaging and their localization on the three-dimensional structure of the protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.01.008

Histidine at Residue 99 and the Transmembrane Region of the Precursor Membrane prM Protein Are Important for the prM-E Heterodimeric Complex Formation of Japanese Encephalitis Virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.01.008

A ligand-binding pocket in the dengue virus envelope glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.01.008

Structure of the dengue virus envelope protein after membrane fusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.01.008

Recombinant, chimaeric live, attenuated vaccine (ChimeriVax) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-hu

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.01.008

Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis anti

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.01.008

Structure of West Nile Virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.01.008

A structural perspective of the flavivirus life cycle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.01.008

Interference in Japanese encephalitis virus infection of Vero cells by a cationic amphiphilic drug, chlorpromazine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.01.008

Role of the transmembrane domains of prM and E proteins in the formation of yellow fever virus envelope.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.01.008

Histidine 39 in the dengue virus type 2 M protein has an important role in virus assembly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.01.008

New developments in flavivirus vaccines with special attention to yellow fever

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.01.008

The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.01.008

Flavivirus membrane fusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.01.008

Characterization of a membrane-associated trimeric low-pH-induced Form of the class II viral fusion protein E from tick-borne encephalitis virus and its crystallization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.01.008

Visualization of membrane protein domains by cryo-electron microscopy of dengue virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.01.008

Structures of immature flavivirus particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.01.008

Conformational changes of the flavivirus E glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.01.008

10.1016/J.VIROL.2007.01.008

7 January 2021

Identifiers

DOI

1 reference

20 September 2017

1 reference